Carling Ursem, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
ORCID ORCID Icon0000-0003-4845-0564 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Columbia UniveristyMDCollege of Physicians and Surgeons
    UC BerkeleyBSMolecular Toxicology
    Duke University Medical CenterResidencyInternal Medicine
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    Dr. Carling Ursem is a medical oncologist with clinical expertise in the management of gastrointestinal and genitourinary malignancies. Her research focus is in prostate cancer clinical trials and specifically expanding clinical trial access to veterans.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Informed decision-making about germline testing among Veterans with advanced prostate cancer (APC): A mixed-methods study. Journal of Clinical Oncology. 2024 Jun 1; 42(16_suppl):5105-5105. Kwon KD, McPhaul MM, Sumra SS, Ursem UC, Walker WE, Scheuner SM, Wang WS, Aggarwal AR, Huang HF, Belkora BJ. .
      View in: Publisher Site   Mentions:
    2. Challenges in patient-centered germline testing delivery for veterans with advanced prostate cancer (APC). Journal of Clinical Oncology. 2024 Feb 1; 42(4_suppl):71-71. Kwon KD, McPhaul MM, Hearst HE, Sumra SS, Ursem UC, Walker WE, Scheuner SM, Wang WS, Aggarwal AR, Huang HF, Belkora BJ. .
      View in: Publisher Site   Mentions:
    3. Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy. Journal of Clinical Oncology. 2023 Jun 1; 41(16_suppl):12040-12040. Lee LH, Walter WL, Smith SA, Shi SY, Boscardin BW, Cohen CH, Williams WG, Zeng ZS, Presley PC, Magnuson MA, Mohile MS, Singhal SS, Ursem UC, Velazquez Manana VA, Gubens GM, Blakely BC, Mulvey MC, Allen AG, Ostrem OJ, Wong WM. .
      View in: Publisher Site   Mentions:
    4. "You have to be sure that the patient has the full picture": Adaptation of the Best Case/Worst Case communication tool for geriatric oncology. J Geriatr Oncol. 2022 06; 13(5):606-613. Wong ML, Nicosia FM, Smith AK, Walter LC, Lam V, Cohen HJ, Loh KP, Mohile SG, Ursem CJ, Schwarze ML. PMID: 35123919; PMCID: PMC9232997.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. SIOG2021-0067* “You have to be sure that the patient has the full picture”: Adaptation of the Best Case/Worst Case (BC/WC) communication tool to geriatric oncology. Journal of Geriatric Oncology. 2021 Dec 1; 12(8):s19-s20. Wong WM, Nicosia NF, Smith SA, Walter WL, Lam LV, Cohen CH, Loh LK, Mohile MS, Ursem UC, Schwarze SM. .
      View in: Publisher Site   Mentions:
    6. Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study. J Am Geriatr Soc. 2022 01; 70(1):136-149. Wong ML, Shi Y, Smith AK, Miaskowski C, Boscardin WJ, Cohen HJ, Lam V, Mazor M, Metzger L, Presley CJ, Williams GR, Loh KP, Ursem CJ, Friedlander TW, Blakely CM, Gubens MA, Allen G, Shumay D, Walter LC. PMID: 34611887; PMCID: PMC8742783.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    7. Changes in functional status associated with radiation for prostate cancer in older veterans. J Geriatr Oncol. 2021 06; 12(5):808-812. Ursem C, Diaz-Ramirez LG, Boscardin J, Lee S. PMID: 33388282; PMCID: PMC8184565.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Embedded palliative care for patients with metastatic colorectal cancer: a mixed-methods pilot study. Support Care Cancer. 2020 Dec; 28(12):5995-6010. Bischoff KE, Zapata C, Sedki S, Ursem C, O'Riordan DL, England AE, Thompson N, Alfaro A, Rabow MW, Atreya CE. PMID: 32285263.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer. Oncologist. 2020 07; 25(7):564-571. Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K. PMID: 32031306; PMCID: PMC7356671.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    10. Mixed methods comparison of functional decline during chemotherapy, immunotherapy (IO), and/or targeted therapy in older adults with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 2019 Nov 1; 37(31_suppl):92-92. Wong WM, Smith SA, Miaskowski MC, Musinipally MV, Cohen CH, Lam LV, Mazor MM, Ursem UC, Loh LK, Cohen CJ, Shumay SD, Levin LA, Dixit DN, Grandi GJ, Walter WL. .
      View in: Publisher Site   Mentions:
    11. P111 “NO ENERGY, ZIP”: A MIXED METHODS COMPARISON OF FUNCTIONAL DECLINE DURING IMMUNOTHERAPY, TARGETED THERAPY, AND/OR CHEMOTHERAPY IN OLDER ADULTS WITH NON-SMALL CELL LUNG CANCER (NSCLC). Journal of Geriatric Oncology. 2019 Nov 1; 10(6):s94-s95. Wong WM, Smith SA, Miaskowski MC, Musinipally MV, Cohen CH, Lam LV, Mazor MM, Ursem UC, Loh LK, Cohen CJ, Shumay SD, Levin LA, Dixit DN, Grandi GJ, Walter WL. .
      View in: Publisher Site   Mentions:
    12. Prognostic factors among older adults with advanced non-small cell lung cancer (NSCLC): A multisite cohort study. Journal of Clinical Oncology. 2019 May 20; 37(15_suppl):11540-11540. Wong WM, Miaskowski MC, Smith SA, Boscardin BW, Cohen CH, Hurria HA, Lam LV, Ursem UC, Blakely BC, Gubens GM, Jahan JT, McCoach MC, Allen AG, Rotow RJ, Dixit DN, Musinipally MV, Webber WK, Walter WL. .
      View in: Publisher Site   Mentions:
    13. Emerging treatment options for BRAF-mutant colorectal cancer. Gastrointest Cancer. 2018; 8:13-23. Ursem C, Atreya CE, Van Loon K. PMID: 29628780; PMCID: PMC5889076.
      View in: PubMed   Mentions: 28  
    14. Association of changes in functional status with radiation for prostate cancer in older veterans. Journal of Clinical Oncology. 2018 Feb 20; 36(6_suppl):148-148. Ursem UC, Diaz-Ramirez DL, Lang-Brown LS, Wei WX, Chen CR, Lee LS. .
      View in: Publisher Site   Mentions:
    15. Clinicopathologic characteristics and impact of oophorectomy for ovarian metastases (ovmets) in colorectal cancer (CRC). Journal of Clinical Oncology. 2018 Feb 1; 36(4_suppl):779-779. Ursem UC, Zhou ZM, Paciorek PA, Atreya AC, Ko KA, Zhang ZL, Van Loon VK. .
      View in: Publisher Site   Mentions:
    16. The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer. Oncology (Williston Park). 2017 11 15; 31(11):785-8, 802. Ursem C, Venook AP. PMID: 29179247; PMCID: PMC5752316.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Symptom Burden in Patients Initiating Treatment for Metastatic Colorectal Cancer (SA527B). Journal of Pain and Symptom Management. 2017 Feb 1; 53(2):408. Cantino CL, Ursem UC, Ritchie RC, Rabow RM, Atreya AC, Bischoff BK. .
      View in: Publisher Site   Mentions:
    18. A model of early integration of palliative care into oncology care for patients with metastatic colorectal cancer. Journal of Clinical Oncology. 2016 Oct 9; 34(26_suppl):142-142. Ursem UC, Cantino CL, Maravilla MI, Thompson TN, Atreya AC, Bischoff BK. .
      View in: Publisher Site   Mentions:
    19. Adjuvant Therapy Trials. Cancer J. 2016 May-Jun; 22(3):196-8. Ursem C, Van Loon K, Venook A. PMID: 27341598; PMCID: PMC5349297.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income. J Womens Health (Larchmt). 2015 May; 24(5):403-8. Ursem CJ, Bosworth HB, Shelby RA, Hwang W, Anderson RT, Kimmick GG. PMID: 25884292.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. Abstract P1-09-05: Does socioeconomic status (SES) influence receipt of guideline concordant care in older women with breast cancer: Findings from a Centers for Disease Control and Prevention national program of cancer registries (NPCR) patterns of care study. Poster Session Abstracts. 2013 Dec 15; p1-09-05-p1-09-05. Ursem UC, Fleming FS, Sabatino SS, Wu WX, Wilson WJ, Lipscomb LJ, Cress CR, Anderson AR, Kimmick KG. .
      View in: Publisher Site   Mentions:
    22. Abstract P1-09-10: Disparities in presentation of breast cancer in a geriatric population. Poster Session Abstracts. 2013 Dec 15; p1-09-10-p1-09-10. Ursem UC, Camacho CF, Anderson AR, Kimmick KG. .
      View in: Publisher Site   Mentions:
    23. Disparities in breast cancer presentation and treatment of older women, by insurance status. Journal of Clinical Oncology. 2013 May 20; 31(15_suppl):e17516-e17516. Ursem UC, Kimmick KG, Anderson AR, Hwang HW, Camacho CF. .
      View in: Publisher Site   Mentions:
    24. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities. Regul Toxicol Pharmacol. 2009 Jun; 54(1):1-22. Ursem CJ, Kruhlak NL, Contrera JF, MacLaughlin PM, Benz RD, Matthews EJ. PMID: 19422096.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities. Regul Toxicol Pharmacol. 2009 Jun; 54(1):23-42. Matthews EJ, Ursem CJ, Kruhlak NL, Benz RD, Sabaté DA, Yang C, Klopman G, Contrera JF. PMID: 19422098.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    26. Surface water quality along the Central John Muir Trail in the Sierra Nevada Mountains: coliforms and algae. High Alt Med Biol. 2009; 10(4):349-55. Ursem C, Evans CS, Ger KA, Richards JR, Derlet RW. PMID: 20039816.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Carling's Networks
    Concepts (77)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (24)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.